[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for …
DS Kyoung, HS Kim - Journal of Lipid and Atherosclerosis, 2021 - pmc.ncbi.nlm.nih.gov
Almost every Korean (97%) is enrolled in the National Health Insurance program, and most
receive medical treatment at least once a year. Data are collected by the Health Insurance …
receive medical treatment at least once a year. Data are collected by the Health Insurance …
[HTML][HTML] Diabetes fact sheets in Korea, 2020: an appraisal of current status
Background This study aimed to investigate the recent prevalence, management, and
comorbidities of diabetes among Korean adults aged≥ 30 years by analyzing nationally …
comorbidities of diabetes among Korean adults aged≥ 30 years by analyzing nationally …
The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study
S Hong, K Han, CY Park - BMC medicine, 2020 - Springer
Abstract Background The triglyceride glucose (TyG) index is an inexpensive clinical
surrogate marker for insulin resistance. However, the relationship between TyG index and …
surrogate marker for insulin resistance. However, the relationship between TyG index and …
Epidemiology of cardiovascular disease and its risk factors in Korea
HC Kim - Global health & medicine, 2021 - jstage.jst.go.jp
Cardiovascular disease (CVD) is the leading cause of death and a major contributor to
disability worldwide. Currently, Korea is among countries with the lowest CVD mortality …
disability worldwide. Currently, Korea is among countries with the lowest CVD mortality …
[HTML][HTML] The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea
Background Coronavirus disease 2019 (COVID-19) is a global pandemic that had affected
more than eight million people worldwide by June 2020. Given the importance of the …
more than eight million people worldwide by June 2020. Given the importance of the …
The metabolic score for insulin resistance (METS-IR) as a predictor of incident ischemic heart disease: a longitudinal study among Korean without diabetes
The metabolic score for insulin resistance (METS-IR) is a novel noninsulin-based marker for
assessing the risk of insulin resistance and cardiometabolic risk. However, whether METS …
assessing the risk of insulin resistance and cardiometabolic risk. However, whether METS …
Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: a …
SJ Han, KH Ha, N Lee, DJ Kim - Diabetes, Obesity and …, 2021 - Wiley Online Library
Aim To examine the real‐world cardiovascular effectiveness and safety associated with
sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor compared with dipeptidyl peptidase‐4 …
sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor compared with dipeptidyl peptidase‐4 …
[HTML][HTML] Response: the risk of diabetes on clinical outcomes in patients with coronavirus disease 2019: a retrospective cohort study (Diabetes Metab J 2020; 44: 405 …
We appreciate Dr. Kim and Professor Kim for their interest and comments on our article
entitled “The risk of diabetes on clinical outcomes in patients with coronavirus disease 2019 …
entitled “The risk of diabetes on clinical outcomes in patients with coronavirus disease 2019 …
[HTML][HTML] Fibrates revisited: potential role in cardiovascular risk reduction
NH Kim, SG Kim - Diabetes & Metabolism Journal, 2020 - synapse.koreamed.org
Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying
drugs. Their main effects are reduction of triglycerides and increase in high-density …
drugs. Their main effects are reduction of triglycerides and increase in high-density …